Abstract
Atopiclair™ and Zarzenda™ (glycyrrhetinic acid/telmesteine/Vitis vinifera) are the brand names for a new topical agent for the treatment of atopic dermatitis and related eczemas. Its activity is purportedly the result of the action and interaction of several of its components, with the lack of any one constituent significantly compromising the efficacy of the end product. These compounds include glycyrrhetinic acid, telmesteine, extracts from V. vinifera, combined with hyaluronic acid, shea butter from Butyrospermum parkii, and glycosaminoglycan for barrier repair purposes.